News
-
Information
C4U has been awarded the “JHVS2021 Venture Award” as a result of the “90-second elevator pitch” at the “Japan Healthcare Venture Summit 2021” held on October 13-15, 2021.
-
Alliance
C4U enters into Non-Exclusive Sublicense Agreement with Nippon Gene
-
IP
The patent for the invention, “A method for detecting specific DNA in the sample”, was issued by Japan Patent Office.Patent registration number: No. 6940086
-
IP
The patent for the invention, “GENOME EDITING METHOD”, was issued by Japan Patent Office.Patent registration number: No. 6948718
-
Information
C4U will participate in BIO JAPAN at PACIFICO Yokohama (JHVS booth V-44).Our CEO Hirai will give a presentation at the pitch event on October 14, 2021 at 2pm.
-
Alliance
C4U enters into Non-Exclusive Sublicense Agreement with iPS Portal
-
Alliance
C4U and National Center for Child Health and Development Started Joint Research
-
Media
C4U has raised $8.5 million (930 million yen) in Series A funding by the end of July.
-
Alliance
C4U and Sumitomo Dainippon Pharma enter into Joint Research and Alliance Agreement
-
Alliance
C4U and Asahi Kasei have entered into the agreement for the joint research and development of a nucleic acid detection kit utilizing CRISPR-Cas3.